The US House of Representatives has proposed regulation that would effectively repeal Title VII of Dodd-Frank, the part that deals with OTC derivatives. This would undue years of rule-making. There is also talk of placing a new emphasis on a Leverage Ratio of 10% while reducing the use of risk-based capital measurements. The arguments for and against this proposal are fast and furious, but so is the reality that the real battle will only happen after the presidential election in November.
This content requires registration. Get access today by signing up here.